Skip to content

Exploration of the effects of HFS-induced secondary hyperalgesia on the NDT-EP method with paired probing stimuli

Exploration of the effects of HFS-induced secondary hyperalgesia on the NDT-EP method with paired probing stimuli - Effects of HFS on the NDT-EP method with paired probing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57266
Enrollment
20
Registered
2025-01-14
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central sensitization

Interventions

Niet van Toepassing

Sponsors

Research Group Biomedical Signal and Systems (BSS), University of Twente
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Age between 18 and 40 years old

Exclusion criteria

Exclusion criteria: - Participant refusal during the study - Language problems - Skin problems at site of stimulation or EEG recording - Diabetes - Small fiber neuropathy - Implanted stimulation device - Pregnancy - Usage of analgesics within 24 hours before the experiment - Consumption of alcohol or drugs within 24 hours before the experiment - Pain complaints at the time of the experiment - A medical history of chronic pain - Having a position of dependency on one or more of the researchers (i.e. being directly supervised and graded by one of the researchers).

Design outcomes

Primary

MeasureTime frame
NDTs, EPs, and subjective ratings (NRS) of the perceived strength of mechanical punctuate stimuli will be collected from a testing (HFS) and a control site, before and 20 minutes after induction of secondary hyperalgesia using HFS.

Secondary

MeasureTime frame
Response Time: Subject*s response time. Participant Characteristics: Age and sex, handedness.

Countries

Netherlands

Contacts

Public ContactJ.R. Buitenweg

Universiteit Twente

j.r.buitenweg@utwente.nl+31(0)534892705

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)